In most areas of the world, Neisseria gonorrhoeae has become increasingly less sensitive to antimicrobials, both in vitro and in vivo, as discussed by Willcox (1970) , Martin, Lester, Price, and Schmale (1970) , and Sparling (1972) . Because of this trend, the doses of penicillin necessary to obtain satisfactory cure rates have greatly increased. The current recommendation by the Venereal Diseases Branch of the U.S. Public Health Service (1972) includes a penicillin injection volume which may be limiting because of local pain.
Throughout the Far East, the frequency of gonococcal strains with reduced antimicrobial sensitivity has been high for many years and has tended to increase, as Willcox (1970) and Reyn (1969) have reported. Thus, the problems experienced elsewhere in establishing adequate treatment regimens for gonorrhoea have been even greater in South-East Asia. We report here the studies conducted to establish effective treatment schedules for gonorrhoea in Bangkok, Thailand. These studies may be relevant to other areas in the Far East and to certain groups in the United States. Patients and methods From December, 1971, to February, 1973, 628 American servicemen with gonococcal urethritis were treated with the current treatment schedule.
DIAGNOSIS
The diagnosis was based upon the demonstration of Gramnegative intracellular diplococci in a smear or the isolation of N. gonorrhoeae from urethral scrapings obtained by inserting a bacteriological loop 1 to 2 cm. into the urethra.
Patients with symptoms of urethritis were interviewed and examined, and smears of urethral material were taken. After April, 1972, urethral Isolates presumed to be Neisseria gonorrhoeae were subcultured on Thayer-Martin medium. Standard sugar fermentation tests were done, using a cystine trypticase agar base. The organism was considered to be N. gonorrhoeae if it was an oxidase-positive, Gram-negative dipplococcus, which fermented 1 per cent. glucose, but failed to ferment 1 per cent. sucrose or lactose. Minimum inhibitory concentrations (MIC) of penicillin were determined using Mueller-Hinton plates containing 0 0, 0 05, 0-1, 0-2, 0 4, 0-6, 0-8, 1 0, 1-2, 1-4, 1-6, 1-8, and 2-0 units per ml. penicillin. Controls employing staphylococcal reference strains and N. gonorrhoeae reference strains from the WHO Reference Laboratory (Dr. A. Reyn) were included.
TREATMENT
Five penicillin treatment schedules were used over the 14 months in six consecutive, non-random treatment periods, and kanamycin was used for patients who were allergic to penicillin (Table I) . Patients who had recurrent disease received either 2 g. kanamycin or 4-8 m.u. procaine penicillin plus 2 g. probenecid; after June, 1972, the latter combination was used for those unable to return for follow-up.
FOLLOW-UP
Most patients were instructed to attend again after 1 week. They were then examined a minimum of 4 hrs after last passing urine and in most cases after holding urine overnight. Smears of urethral scrapings were taken from all patients, and cultures of urethral scrapings were done at the follow-up examination for all patients seen after April, 1972. Two-glass urine specimens were acidified and examined grossly for haze, heavy threads, or clumps.
Patients were considered to have been followed if they returned within 3 weeks of therapy. All patients who had N. gonorrhoeae demonstrated at the follow-up visit were defined as having recurrent disease. This group thus includes patients that others would classify as having either a re-infection or a relapse. group.bmj.com on November 6, 2017 -Published by http://sti.bmj.com/ Downloaded from plus 4 8 m.u. procaine penicillin were used nearly 10 weeks apart in Schedules 3 and 5, but had similar recurrence rates of 5-6 and 7-5 per cent. The combined recurrence rate for this therapy was 6 5 per cent. (eleven recurrences in 169 patients followed). The use of 3-5 g. ampicillin plus 2 g. probenecid (Schedule 4) was associated with recurrent disease in five of 69 patients followed (7 2 per cent.). Nongonococcal infections in this group were, however, severe (vide infra). Recurrence after 2 g. probenecid plus 5 m.u. sodium penicillin G (Schedule 6) occurred in seven of 83 patients followed (8-4 per cent.). After 2 g. kanamycin, used to treat patients allergic to penicillin, only one recurrence was observed in the eighteen patients followed. Throughout the study, the percentage of patients who were followed remained relatively constant, ranging from 58 to 70 per cent. in the various treatment groups (Table II) (Phillips, Humphrey, Middleton, and Nicol, 1971; Holmes, Johnson, and Floyd, 1967; Maurer and Schneider, 1969; Ashamalla, Walters, and Crahan, 1966; Eriksson, 1970; Tiedemann, Hackney, and Price, 1965) . Our ability to isolate the organism in 94 per cent. of cases suggests that the technical difficulties with smears listed by Willcox (1970) were avoided in these studies. Although only 2 per cent. of our cases were identified by cultures alone, this figure is estimated at 5 to 7 per cent. if the patients had been seen on only one occasion.
Results
The number of strains of gonococci with reduced sensitivity to penicillin in vitro in this unselected group of isolates was high, 89 per cent. having an MIC of 0-1 u./ml. or greater, more than 50 per cent. 0-6 u/ml. or greater, and 12 per cent. 1 u./ml. or greater. Suvanamalik (1971) reported that 37 per cent. of unselected strains from elsewhere in Bangkok had an MIC of 0 5 u/ml. or greater. More recent studies have documented an increase in the degree of insensitivity of strains at this laboratory (personal communication with Dr. S. Suvanamalik). These do not approach the degree of insensitivity found by Reyn (1969) , but the strains she reported on may have been from 'problem cases' in Thailand.
CLINICAL OBSERVATIONS
The use of 2 f4 m.u. procaine penicillin 1 hr after 1 g. probenecid was based on the success reported by Holmes and others (1967) , Holmes, Johnson, Stewart, and Kvale (1968) , and Keyes, Halverson, and Clarke (1969) in other areas with 'resistant' gonorrhoea. This was quickly demonstrated to be an unsuccessful regime, recurrent disease being noted in 50 per cent. of cases. Doubling the dose of procaine penicillin decreased the recurrence rate, but only to 31 per cent.
Because of local pain, 4-8 m.u. procaine penicillin seemed to be near the maximum single-session dose. Meads, Knight, and Izlar (1951) and Frisk, Diding, and Wallmark (1952) have reported that the enhancement of serum penicillin levels by probenecid is dose-related up to 4 g., and Boger and Strickland (1955) suggested that toxicity as a result of shortterm administration of this drug was minimal. Recently, Cornelius, Schroeter, Lester, and Martin (1971) and the British Medical J7ournal (1968) (quoting unpublished observations of F. R. Curtis) reported that the use of 2 g. probenecid in combination with large doses of procaine penicillin caused no serious side-effects. We therefore increased the dose of probenecid to 2 g. and gave 4 8 m.u. procaine penicillin 1 hr later. A recurrence rate of less than 7 per cent. was found with this combination, and 2 g. probenecid was therefore used in all subsequent penicillin trials.
Oral therapy is painless and is possibly associated with fewer severe allergic reactions than parenteral administration. A single-session oral dose of ampicillin plus probenecid had been successfully used in cases of gonorrhoea in the Philippines by Kvale, Keyes, Johnson, and Holmes (1971) , so this method was included in our studies. Although we were unable to demonstrate gonococcal recurrence in more than five out of 69 patients, the frequency and severity of apparent post-gonococcal urethritis that we observed precludes further use of this combination in our clinic.
Olsen and Lomholt (1969) used a combination of 1 g. probenecid and 5 0 m.u. sodium penicillin G, and reported no significant side-effects during 4 years of use. Morton and Onn (1971) reported that this combination was successful in Singapore, where insensitivity in vitro is as common as in Bangkok.
Acceptance of this single injection by patients was also excellent. Our results with this combination were not significantly different from those for Schedules 3, 4, 5, or 7, although 8 4 per cent. of patients had recurrent disease.
Both the studies in vitro of Suvanamalik (1971) and unpublished clinical studies in Bangkok suggested that tetracycline was not the best therapy here. We therefore used kanamycin for the initial therapy of patients allergic to penicillin. Although the number treated was small, this seemed to be a satisfactory drug. (Spectinomycin was not available during most of this time.)
Since we were unable to differentiate reliably between patients with re-infection and those with relapse, both groups were considered under the heading 'recurrence'. Patients with recurrent disease were seen an average of 10 7 days after therapy and seven of 24 patients in Groups 3 to 7 returned during the third week of follow-up. The MIC values for those with recurrences were not significantly higher than for the entire group. This suggests that a large number of the cases included in our recurrence group were re-infected, and would explain our inability to achieve more than a 92 to 94 per cent. cure rate with these treatment schedules. It is interesting to note that Holmes and others (1968) inferred a 6 per cent. re-infection rate in patients followed over a 3-week period. 
